Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing Surgery

Clinical trial NCT04370509 · TERMINATED

Trial details

NCT number: NCT04370509
Sponsor: University of California, San Francisco
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Clear Cell Renal Cell Carcinoma Recurrent Clear Cell Renal Cell Carcinoma Stage III Renal Cell Cancer AJCC v8 Stage IV Renal Cell Cancer AJCC v8 Clear Cell Renal Cell Carcinoma

Start date: 2021-02-09
Primary completion: 2025-02-28
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.